Medipost Co (Medipost Co) 3-Year Book Growth Rate : 12.20% (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Medipost Co 3-Year Book Growth Rate?

Medipost Co's Book Value per Share for the quarter that ended in Mar. 2024 was $29.57.

During the past 12 months, Medipost Co's average Book Value per Share Growth Rate was -3.30% per year. During the past 3 years, the average Book Value per Share Growth Rate was 12.20% per year. During the past 5 years, the average Book Value per Share Growth Rate was 8.60% per year. During the past 10 years, the average Book Value per Share Growth Rate was 2.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Medipost Co was 26.80% per year. The lowest was -7.60% per year. And the median was 4.40% per year.

Competitive Comparison of Medipost Co's 3-Year Book Growth Rate

For the Biotechnology subindustry, Medipost Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medipost Co's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medipost Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Medipost Co's 3-Year Book Growth Rate falls into.

Medipost Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Medipost Co (OTCPK:MEPTF) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Medipost Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Medipost Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Medipost Co (Medipost Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (OTCPK:MEPTF) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

078160:Korea

Address

21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR

Website

http://www.medi-post.co.kr

Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (Medipost Co) Headlines

No Headlines